122 322

Cited 0 times in

Specialist Perception of Severe Asthma in Korea: A Questionnaire Survey

Authors
 Mi Ae Kim  ;  Heung Woo Park  ;  Byung Keun Kim  ;  So Young Park  ;  Ga Young Ban  ;  Ji Hyang Lee  ;  Jin An  ;  Ji Su Shim  ;  Youngsoo Lee  ;  Ha Kyeong Won  ;  Hwa Young Lee  ;  Kyoung Hee Sohn  ;  Sung Yoon Kang  ;  So Young Park  ;  Hyun Lee  ;  Min Hye Kim  ;  Jae Woo Kwon  ;  Sun Young Yoon  ;  Jae Hyun Lee  ;  Chin Kook Rhee  ;  Ji Yong Moon  ;  Taehoon Lee  ;  So Ri Kim  ;  Jong Sook Park  ;  Sang Heon Kim  ;  Jae Won Jeong  ;  Sang Hoon Kim  ;  Young Il Koh  ;  Yeon Mok Oh  ;  An Soo Jang  ;  Kwang Ha Yoo  ;  You Sook Cho 
Citation
 ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, Vol.13(3) : 507-514, 2021-05 
Journal Title
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH
ISSN
 2092-7355 
Issue Date
2021-05
Keywords
Asthma ; biological products ; consensus ; diagnosis ; disease management ; standards ; surveys and questionnaires ; therapeutics
Abstract
The Working Group on Severe Asthma of the Korean Academy of Allergy and Clinical Immunology recently published an expert opinion paper on the management of severe asthma in Korea. When developing a consensus, the working group encountered several diagnostic and treatment issues and decided to perform a questionnaire survey of Korean specialists with regard to severe asthma. An e-mail with a uniform resource locator link to the questionnaire was sent to 121 asthma specialists, of whom 44.6% responded. The most commonly accepted definitions of severe asthma were a history of fatal exacerbation or an asthma-triggered need for mechanical ventilation, 3-4 oral corticosteroid (OCS) bursts/year, and maintenance of OCS therapy for 3-6 months per year. Before diagnosing severe asthma, most physicians contemplate chest computed tomography, seek to control chronic rhinosinusitis, and consider poor inhaler compliance. For patients with uncontrolled severe asthma accompanied by type 2 (T2)-high inflammation, most biologics available in Korea were considered appropriate, but gaps were apparent in terms of T2-low asthma treatments. These findings about specialist perception of diagnosis and treatment of severe asthma will inform the use of emerging new drugs and facilitate personalized therapy.
Files in This Item:
T202104683.pdf Download
DOI
10.4168/aair.2021.13.3.507
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Lee, Jae Hyun(이재현) ORCID logo https://orcid.org/0000-0002-0760-0071
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/186808
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links